Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical silymarin vs 2% hydroquinone for melasma (randomized double-blind split-face)
TCTR20210729003Phase 2Completed
- Sponsor
- N/A
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silymarin, hydroquinone in melasma, sponsored by N/A. Started May 2017; status: completed.
02
Drugs
silymarinhydroquinone
03
Conditions
melasma
Beyond the preview
Go deeper on TCTR20210729003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210729003.